INS and type 2 diabetes mellitus: Treatment of Goto-Kakizaki rats, a spontaneous nonobese model that develops T2D, with infra-therapeutic doses of lithium, a widely used inhibitor of GSK3, reduced the expression of pro-inflammatory cytokines in the pancretic islets, partially restored the glucose-induced insulin secretion, and reduced the development of diabetes (64).